Ophir Asset Management Pty LTD Harrow Health, Inc. Transaction History

Ophir Asset Management Pty LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$9.3 - $13.23 $3.73 Million - $5.31 Million	-401,563 Reduced 73.26%	146,567 $1.94 Million
Q4 2023 Feb 14, 2024	BUY	$8.1 - $16.36 $453,203 - $915,358	55,951 Added 11.37%	548,130 $6.14 Million
Q3 2023 Nov 14, 2023	BUY	$14.03 - $22.08 $1.93 Million - $3.04 Million	137,500 Added 38.77%	492,179 $7.07 Million
Q2 2023 Aug 11, 2023	SELL	$17.37 - $28.08 $1.45 Million - $2.34 Million	-83,455 Reduced 19.05%	354,679 $6.75 Million
Q1 2023 May 15, 2023	SELL	$13.84 - $21.46 $4.58 Million - $7.1 Million	-330,782 Reduced 43.02%	438,134 $9.27 Million
Q4 2022 Feb 14, 2023	SELL	$10.28 - $14.78 $907,888 - $1.31 Million	-88,316 Reduced 10.3%	768,916 $11.3 Million
Q3 2022 Nov 14, 2022	SELL	$6.57 - $24.88 $4.1 Million - $15.5 Million	-623,735 Reduced 42.12%	857,232 $10.3 Million
Q2 2022 Jul 26, 2022	SELL	$5.75 - $7.74 $3.2 Million - $4.3 Million	-555,662 Reduced 27.28%	1,480,967 $10.8 Million
Q1 2022 May 16, 2022	BUY	$6.77 - $8.66 $888,731 - $1.14 Million	131,275 Added 6.89%	2,036,629 $13.9 Million
Q4 2021 Feb 14, 2022	BUY	$8.5 - $12.0 $1.15 Million - $1.63 Million	135,684 Added 7.67%	1,905,354 $16.5 Million
Q3 2021 Nov 12, 2021	BUY	$6.99 - $10.6 $690,982 - $1.05 Million	98,853 Added 5.92%	1,769,670 $16.1 Million
Q2 2021 Aug 09, 2021	BUY	$6.68 - $11.07 $2.58 Million - $4.27 Million	385,498 Added 29.99%	1,670,817 $15.5 Million
Q1 2021 May 17, 2021	BUY	$6.26 - $11.03 $8.05 Million - $14.2 Million	1,285,319 New	1,285,319 $8.48 Million

177

21.4M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $992M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Ophir Asset Management Pty LTD, based on Form 13F filings with the SEC.

Stay updated on Ophir Asset Management Pty LTD with notifications on news.